Showing results (831-840 of 12,391) with videos related to
Sort By:
Pageof 1,240
Journal of Alzheimer'S Disease : JAD|June 20, 2012
Dietary antioxidants and dementia in a population-based case-control study among older people in South GermanyChristine A F von Arnim, Florian Herbolsheimer, Thorsten Nikolaus, et al.Journal of Alzheimer'S Disease : JAD|July 17, 2012
Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease interventionAndrew B Wolf, B Blair Braden, Heather Bimonte-Nelson, et al.Journal of Alzheimer'S Disease : JAD|September 15, 2012
The effect of an aloe polymannose multinutrient complex on cognitive and immune functioning in Alzheimer's diseaseJohn E Lewis, H Reginald McDaniel, Marc E Agronin, et al.Journal of Alzheimer'S Disease : JAD|September 21, 2012
Anatomical MRI and DTI in the diagnosis of Alzheimer's disease: a European multicenter studyStefan J Teipel, Martin Wegrzyn, Thomas Meindl, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2012
Potential immunotargets for Alzheimer's disease treatment strategiesPatricia L Fernández, Gabrielle B Britton, K S RaoJournal of Alzheimer'S Disease : JAD|July 13, 2012
DAPK1 is associated with FTD and not with Alzheimer's diseaseAndrea Tedde, Irene Piaceri, Silvia Bagnoli, et al.Journal of Alzheimer'S Disease : JAD|July 13, 2012
Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trialsBob Olsson, Clas Malmeström, Hans Basun, et al.Journal of Alzheimer'S Disease : JAD|July 13, 2012
Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's diseasePascale Fehlbaum-Beurdeley, Olivier Sol, Laurent Désiré, et al.Journal of Alzheimer'S Disease : JAD|July 13, 2012
Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?William L KleinJournal of Alzheimer'S Disease : JAD|March 24, 2010
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive declineCristoforo Comi, Miryam Carecchio, Annalisa Chiocchetti, et al.Pageof 1,240